Proc Natl Acad Sci U S A 95: 29562960
Overlapping Risks and Clinical Evidence Gaps Co-administration of HCG and semaglutide introduces compounding uncertainties: additive nausea, unpredictable blood-sugar fluctuations, and unknown effects on reproductive-axis hormones during GLP-1 therapy
Glutathione l phn t gii c quan trng nht nh lng c t v cc gc t do gy hi, trong khi vitamin C khng ch tiu dit cc gc t do m cn bo v glutathione khi b oxy ha, gip duy tr v tng cng hot ng ca glutathione trong c th.Khng nhng th, c hai u gp phn tng cng sc bn v kh nng chng ca c th, gip tng trng c bp, ngn nga tch t m v nng cao tui th
For patients requiring long-term treatment, hydrogel carriers can provide continuous drug release and reduce the frequency of administration
But side effects are still possible, especially when taken at higher doses